Zura Bio ZURA
NASDAQ ZURA
$4.11 -0.03 (-0.61%)
As of: Oct 22, 2026 · 2:27 PM EDT

Zura Bio (ZURA) Receivables - Other (2022)

Updated

Zura Bio's Receivables - Other came in at $5,144 for Q1 2022.

Analysis

Zura Bio (ZURA) Receivables - Other (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,171.69 Bn 1,140.28 Bn 19.71 Bn
2 Johnson & Johnson 649.22 Bn 569.08 Bn 17.30 Bn
3 AbbVie 504.17 Bn 477.29 Bn 12.70 Bn
4 Merck 366.35 Bn 320.73 Bn 12.21 Bn
5 Novartis Ag 303.54 Bn 267.53 Bn 11.24 Bn
6 Astrazeneca 269.49 Bn 243.18 Bn 12.86 Bn
7 Amgen 242.61 Bn 198.01 Bn 7.24 Bn
8 Gilead Sciences 195.09 Bn 169.29 Bn 6.22 Bn
9 Pfizer 172.48 Bn 119.12 Bn 10.94 Bn
10 Zura Bio 520.53 Mn -158.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 5,144.00
API Access

Zura Bio Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ZURA&period=max&api_key=YOUR_API_KEY